Get the Stockscreener App
12.20
2.40%
-0.2999
After Hours:
11.62
-0.58
-4.75%
Surrozen Inc stock is traded at $12.20, with a volume of 90,304.
It is down -2.40% in the last 24 hours and down -11.27% over the past month.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
See More
Previous Close:
$12.50
Open:
$11.65
24h Volume:
90,304
Relative Volume:
3.27
Market Cap:
$104.56M
Revenue:
-
Net Income/Loss:
$-53.45M
P/E Ratio:
-0.562
EPS:
-21.71
Net Cash Flow:
$-31.81M
1W Performance:
-12.86%
1M Performance:
-11.27%
6M Performance:
+31.89%
1Y Performance:
+19.73%
1-Day Range:
$11.51
$12.50
1-Week Range:
$11.39
$14.31
52-Week Range:
$5.90
$18.17
Surrozen Inc Stock (SRZN) Company Profile
Name
Surrozen Inc
Sector
Industry
Phone
650-475-2820
Address
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
12.20 | 107.13M | 0 | -53.45M | -31.81M | -21.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Initiated | H.C. Wainwright | Buy |
| Jan-03-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Sep-15-21 | Initiated | Guggenheim | Buy |
| Sep-07-21 | Initiated | Stifel | Buy |
Surrozen Inc Stock (SRZN) Latest News
Surrozen Ramps Up R&D Spending Despite Mounting Losses - Finimize
Surrozen Incon Nov 6, Andrew Maleki appointed as CFO effective November 12, 2025SEC filing - MarketScreener
Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Biotechnology firm Surrozen's Q3 net loss widens on higher R&D costs - MarketScreener
Surrozen, Inc. Reports Third Quarter 2025 Financial Results and Business Updates in Ophthalmology Pipeline - Quiver Quantitative
Surrozen (NASDAQ: SRZN) names CFO Andrew Maleki as update notes $81.3M cash - Stock Titan
What insider trading reveals about Surrozen Inc. stockQuarterly Risk Review & Real-Time Buy Zone Alerts - newser.com
Applying Wyckoff theory to Surrozen Inc. stockJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
How Surrozen Inc. Equity Warrant stock compares to market leadersMarket Activity Summary & Technical Pattern Based Buy Signals - newser.com
Understanding Surrozen Inc.’s price movement2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com
What earnings revisions data tells us about Surrozen Inc. Equity WarrantTreasury Yields & Weekly Market Pulse Updates - newser.com
Custom watchlist performance reports with Surrozen Inc.July 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Smart tools for monitoring Surrozen Inc. Equity Warrant’s price actionPortfolio Gains Report & Daily Stock Trend Reports - newser.com
How to interpret RSI for Surrozen Inc. stockJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
What to do if you’re stuck in Surrozen Inc. Equity Warrant2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
What’s next for Surrozen Inc. Equity Warrant stock priceRecession Risk & Verified Entry Point Detection - newser.com
Using Ichimoku Cloud for Surrozen Inc. technicalsEarnings Overview Report & Free Technical Pattern Based Buy Signals - newser.com
Will Surrozen Inc. stock benefit from sector rotationPortfolio Return Report & Smart Allocation Stock Tips - newser.com
Is Surrozen Inc. Equity Warrant a candidate for recovery play2025 Performance Recap & Consistent Income Trade Ideas - newser.com
Will Surrozen Inc. Equity Warrant outperform the marketGlobal Markets & Low Risk Growth Stock Ideas - newser.com
What makes CareDx, Inc stock price move sharply - newser.com
How to forecast Surrozen Inc. Equity Warrant trends using time seriesJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com
How Surrozen Inc. Equity Warrant stock performs in weak economyJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
What hedge fund activity signals for Surrozen Inc. stockMarket Movers & AI Based Trade Execution Alerts - newser.com
How Surrozen Inc. stock reacts to oil pricesPortfolio Gains Report & Daily Growth Stock Tips - fcp.pa.gov.br
Is Surrozen Inc. stock a good choice for value investorsQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
Will Surrozen Inc. stock deliver consistent dividends2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
How Surrozen Inc. Equity Warrant stock performs in rising dollar environmentEntry Point & Safe Capital Investment Plans - newser.com
What is the fair value of Surrozen Inc. Equity Warrant stock nowJuly 2025 Review & High Conviction Investment Ideas - newser.com
What recovery options are there for Surrozen Inc. Equity WarrantEarnings Miss & Stock Portfolio Risk Management - newser.com
Why analysts upgrade Surrozen Inc. stockPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Will a bounce in Surrozen Inc. Equity Warrant offer an exitJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
Volatility Watch: How strong is Surrozen Inc. stock revenue growthJuly 2025 PostEarnings & Entry Point Strategy Guides - fcp.pa.gov.br
Applying sector rotation models to Surrozen Inc. Equity WarrantJuly 2025 Catalysts & Detailed Earnings Play Strategies - newser.com
Surrozen to Present at Upcoming Healthcare Investor Conference - The Manila Times
Surrozen (NASDAQ: SRZN) sets Nov. 12, 6:30 AM PT fireside chat at Guggenheim conference - Stock Titan
US Stock Market top gainers and losers on November 4: Surrozen, Inc sees 220% jump, Tradr 2X Long SRPT Dai - The Economic Times
Surrozen Inc Stock (SRZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):